Utilizing my past 20+ years of experience in Pharmaceutical and Pharmaceutical Cannabis to develop and expand the sales of our most awaited and wonderful solution in East Coast.NeuroTags enables the digital capabilities in Brands, to help them protect their consumers (anti-counterfeiting solution), acquire (signup) them in physical world, re-engage them for repeat sales and tracking and tracing the supply chain for the complete control, visibility and efficiency.

Responsible for Verdant AgriFactories sales and business development activities in the New England Region, including Connecticut, Rhode Island, Massachusetts ,Vermont, New Hampshire and Maine.The Verdant Global Mission is to put the highest quality produce on every consumer’s plate by utilizing the most advanced, environmentally sustainable technologies available.The Verdant Global Vision:A major challenge facing our planet is to produce sufficient and readily available, nutritious food. This is becoming more acute as the availability of farmable land, clean water and affordable energy are factored against our skyrocketing global population. We need to find more scalable, flexible and resource efficient ways to feed 9 billion humans by 2050.Verdant Global offers a powerful solution to these issues by growing highly nutritious food - anywhere on the planet - efficiently and cleanly in its indoor, vertically tiered Verdant AgriFactorieswww.verdantglobal.com

Worked with partners to start FIR Company Researched Far Infrared Technology, WS Therapy Far Infrared Units from Taiwan, to evaluate their clinical effect on dialysis access failures rates Meet with renal research physicians in the U.S. to help evaluate published clinical trials regarding FIR. Assessed market need for FIR technology in Dialysis access failure in the U.S. Developed marketing plan for FIR technology in U.S. dialysis market. Researched reimbursement models for payment for FIR in ESRD market. Traveled to Taiwan to meet with principals of WS FAR Company to evaluate and negotiate a deal for the rights to sell FIR in the U.S. Helped negotiate deal with WS FAR to secure U.S. rights for FIR technology Meet with Dr. Lin in Taiwan, at that time Dr Lin had published two studies in U.S. journals regarding far Infrared technology for use in dialysis access. Visited physician’s and dialysis centers in Taiwan that were utilizing FIR technology. Meet with thought leaders in Dialysis Access Consortium Group to grow awareness of FIR. Arranged to have a study conducted using FIR for dialysis access at a major medical center. Arranged meetings with Nephrology thought leaders from the U.S. to meet with Dr. Lin to discuss his research on FIR for dialysis access failure. Attended ASN meetings to promote Far Infrared Technology.

Promoted to Hospital System Manager Served as the primary customer contact of an integrated sales team in promoting oncology and nephrology products to assigned hospitals in Boston, Providence, Hartford and Springfield Massachusetts. Developed strengthened and expanded relationships with physicians, pharmacists, nurse practioners, nurses and executive management. Achieved and exceeded ambitious sales targets through the effective and persistent execution of marketing strategy plans. Maintained, negotiated and managed hospital contracts. Developed thought leaders and delivered medical education programs to impact business. Successful at formulary additions and therapeutic interchanges at major medical institutions in New England. Launched four products in Oncology, Aranesp - Neulasta - Kepivance – Vectibix Five time President Awards Winner

Management moved me from previous territory, Maine, New Hampshire and Northern Massachusetts to the influential Boston territory in preparation for the launch of Aranesp in the nephrology market. Responsible for the dialysis centers in the Boston and the surrounding areas. Responsible for major medical institutions in Boston including Massachusetts General, Brigham & Women’s, Beth Israel Deaconess, Boston Children's Hospital, Tufts Medical Center, Boston Medical Center. Successfully launched Aranesp in chronic kidney disease market. Attained formulary approval for Aranesp at seven Boston medical institutions

Used consultative sales approach to increase epogen business in Maine, New Hampshire and Northern Massachusetts.Formed strong relationships with physicians and nurses by providing them with data to help improveoutcomes when dosing epogen.Helped nurses to develop specialized knowledge in anemia management.Responsible to call on Regional Directors of dialysis chains at Fresinius Medical Care and Gambro Healthcare for business reviews.Responsible for dialysis and pharmacy business at Lahey Clinic, Dartmouth Hitchcock Medical Center, Beverly Hospital, Lowell General, Saints Memorial, Maine Medical Center - Eastern Maine Medical Center and Southern NH Medical CenterWith no prior dialysis sales experience became # 1 in district sales for 1997 and 1998, ranked #2in district sales in 1999.Promoted to Boston territory,managed both territories for 6 months while a replacement was hired.